One of Maryland’s best-funded biotech companies took a milestone first step Monday, announcing it has begun clinical trials of a medication it is developing. Gaithersburg-based Viela Bio was spun out of MedImmune, a subsidiary of AstraZeneca, last month with $250 million in ...

Tagged with: clinical study medimmune Viela Bio

MedImmune spun out Viela Bio as an independent biotechnology company with $250 million in Series A financing and six potential medicines, the companies announced Wednesday. Viela Bio will be based in Gaithersburg and will focus on inflammation and autoimmunity biologics, ...

Tagged with: AstraZeneca medimmune Viela Bio

Johns Hopkins University is launching a new Ph.D program that will offer students hands-on work experience in the biopharmaceutical field, where they’ll learn about the process of discovering and developing new drugs. Officials say the partnership between the university and ...

Tagged with: johns hopkins university medimmune Ronald Daniels

FREDERICK — The city of Frederick has finalized a loan package that will approve expansion of MedImmune’s Frederick biotech manufacturing plant and improve roads around the business. The Frederick News-Post reports that the Board of Aldermen voted Thursday to approve ...

Tagged with: medimmune

FREDERICK — The Frederick County Council has voted to financially support the expansion of MedImmune’s Frederick manufacturing plant, a project the company says will bring 300 new jobs. The Frederick News-Post reports that, in a 6-1 vote, the County Council ...

Tagged with: medimmune

Gaithersburg-based MedImmune, the biologics research and development arm of AstraZeneca, has been certified by the Department of Energy’s Superior Energy Performance program for improvements at its headquarters facility. MedImmune is the first company in Maryland  to achieve the certification, the ...

Tagged with: medimmune

Gaithersburg-based MedImmune is expanding its recently announced research partnership with the University of Maryland, Baltimore to include two more UM campuses: College Park and Baltimore County.

Tagged with: AstraZeneca medimmune research umb umbc umcp University System of Maryland

Gaithersburg-based MedImmune has entered into a three-year partnership with the Clinical and Translational Science Institute at the University of California, San Francisco.

Tagged with: medimmune

The University of Maryland, Baltimore and MedImmune Inc., of Gaithersburg, a subsidiary of British drug maker AstraZeneca PLC, announced they have entered into a five-year, $6 million agreement to work on novel bioscience research in Maryland.

Tagged with: Baltimore breaking news collaboration medicine medimmune merger science University of Maryland

TRENTON, N.J. — Struggling Anglo-Swedish drugmaker AstraZeneca PLC said Monday that it will eliminate 1,600 jobs, mostly in the U.S. and United Kingdom, as its new CEO starts a major research and development reorganization. The cuts, meant to reduce costs ...

Tagged with: Business Economy gaithersburg maryland medimmune reorganization